MZMakhloufi Zoulikha
Makhloufi Zoulikha
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Makhloufi Zoulikha has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Qingqing Xiao
School of Pharmacy, China Pharmaceutical University, Nanjing 2111198, China
3 shared publications- Wei He
School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
3 shared publications George Frimpong Boafo
2 shared publicationsXiaotong Li
School of Pharmacy, China Pharmaceutical University, Nanjing 2111198, China
2 shared publicationsYi Yang
Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China
2 shared publicationsChao Teng
1 shared publication
Latest Publications
- Open Access
- 26 May 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (11) , 4607-4620
Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation
- 26 May 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (11) , 4607-4620
Open AccessPulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation
- 17 April 2022
- Published by Elsevier in Chinese Chemical Letters
- Vol. 33 (10) , 4600-4604
Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes
- 17 April 2022
- Published by Elsevier in Chinese Chemical Letters
- Vol. 33 (10) , 4600-4604
Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes
- Top Cited PapersOpen Access
- 1 February 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (2) , 600-620
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
- 1 February 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (2) , 600-620
Top Cited PapersOpen AccessPulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome